Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cetuximab (erbitux) (1 trial)
irinotecan (Camptosar) (1 trial)
lm-302 (1 trial)
Colorectal Neoplasms (Phase 3)
Trials (2 total)
Trial APIs (3 total)